News Sentiment

HLN sentiment intelligence

Haleon plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 55 Balanced news tone 53 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 8.96 Week of 19 Jun 2026
Weighted tone 55/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

77/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-1.9% over one week, -3.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Haleon (NYSE: HLN) details 14.3M-share buyback and new voting capital

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 77/100 classification
One-week reaction -1.9% Price digesting
Trend fit Trend inactive -3.6% over four weeks
Fair value -1.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 21
Neutral 25
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
AD HOC NEWS 10
Stock Titan 9
Bez Kabli 7
Market source 5
TradingKey 4
TradingView 3
simplywall.st 2
Simply Wall Street 1

Event Lens

What the news is about

Classified themes
Market update 25
Capital return 12
Earnings 6
Analyst action 4
Guidance 3
Regulatory and legal 1
Deals and strategy 1
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 53
TradingView Direct company coverage

REG - Haleon PLC - Transactions in Own Shares

Haleon PLC announced the purchase of 14,288,204 ordinary shares for cancellation under its share buyback programme, initially announced on March 12, 2026. The aggregated information provides details of share purchases between June 16 and June 18, 2026, across different exchanges,

Tone
Positive 72/100
Event
Capital return
Published
22 Jun 2026 06:10
Source
TradingView
Bez Kabli Direct company coverage

Haleon shares slip into the weekend after Redburn downgrade tests recovery hopes

Haleon's shares slipped after Redburn downgraded the stock to Neutral with a 365p price target, raising doubts about the company's U.S. recovery. Despite a £500 million share buyback program offering some support, the company faces challenges with cautious U.S. shoppers and slow

Tone
Negative 36/100
Event
Capital return
Published
20 Jun 2026 19:39
Source
Bez Kabli
Market source Direct company coverage

Haleon (HLN) Issues Voluntary Nationwide Recall for Specific Gas-X Extra Strength Softgels

Haleon (HLN) has initiated a voluntary nationwide recall for specific lots of its Gas-X Extra Strength Softgels due to potential contamination from a diluted propylene glycol-based coolant. Although no adverse health events have been reported, the company is taking precautionary

Tone
Negative 29/100
Event
Regulatory and legal
Published
19 Jun 2026 17:10
Source
Market source
Bez Kabli Direct company coverage

Haleon shares nudge up with brokers mixed on U.S. recovery view

Haleon shares saw a slight increase even as brokers presented mixed views on the potential for a U.S. recovery, with Rothschild & Co Redburn cutting its rating and Morgan Stanley trimming its price target. Investors are closely watching for Haleon's first-half results on July 30

Tone
Neutral 50/100
Event
Analyst action
Published
19 Jun 2026 13:10
Source
Bez Kabli
TradingKey Direct company coverage

Haleon PLC (HLN) Institutional Confidence

Haleon PLC (HLN) has an institutional shareholding score of 3.00, placing it 94th out of 157 in the Pharmaceuticals industry. Institutional investors hold 12.97% of shares, a 5.63% increase quarter-over-quarter. First Eagle Investment is the largest institutional shareholder, hol

Tone
Positive 64/100
Event
Market update
Published
19 Jun 2026 08:11
Source
TradingKey
TradingKey Direct company coverage

Haleon PLC (HLN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Haleon PLC (HLN) has an earnings forecast score of 7.60, ranking 98 out of 157 in the Pharmaceuticals industry, with an average analyst price target of $11.50. Based on ratings from 5 analysts, the consensus is a "Buy" recommendation for the stock. The article highlights key fina

Tone
Positive 67/100
Event
Earnings
Published
18 Jun 2026 20:39
Source
TradingKey
Simply Wall Street Direct company coverage

One Haleon Insider Has Reduced Their Stake

One Haleon insider, CEO Brian McNamara, sold UK£464k worth of shares in the last year, although this sale was at a price above the current share price. While there was some insider buying, the selling significantly outweighed the buying, suggesting some insiders might believe the

Tone
Negative 38/100
Event
Deals and strategy
Published
18 Jun 2026 16:40
Source
Simply Wall Street
TradingKey Direct company coverage

Haleon PLC (HLN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed breakdown of Haleon PLC's (HLN) revenue by business segment and geographical region for the fiscal year 2023. It highlights Oral Health, Pain Relief, and Respiratory Health as key contributors to revenue, alongside significant regional contributio

Tone
Neutral 50/100
Event
Earnings
Published
18 Jun 2026 15:40
Source
TradingKey
Bez Kabli Direct company coverage

Haleon slips after Redburn downgrade with eyes on U.S. and July earnings

Haleon's shares slipped after Rothschild & Co Redburn downgraded the stock to Neutral, impacting its position on the FTSE 100. Investors are concerned about sales growth prospects, particularly a rebound in North America and overall volume increases, ahead of the H1 2026 results

Tone
Negative 37/100
Event
Earnings
Published
16 Jun 2026 14:40
Source
Bez Kabli
Investing.com Direct company coverage

Haleon buys back 565,285 shares for cancellation on London Stock Exchange

Haleon plc announced it purchased and cancelled 565,285 ordinary shares as part of its ongoing share buyback program. The transactions occurred on June 8, 2026, on the London Stock Exchange, with a volume weighted average price of 331.9552 pence per share. Following these transac

Tone
Positive 67/100
Event
Capital return
Published
16 Jun 2026 07:39
Source
Investing.com
Stock Traders Daily Direct company coverage

Understanding Momentum Shifts in (HLN)

This article analyzes Haleon Plc (HLN) using AI models, identifying a near-term strong sentiment but a neutral mid and long-term outlook. It highlights a significant 22.7:1 risk-reward setup targeting a 7.6% gain and outlines specific institutional trading strategies including po

Tone
Neutral 50/100
Event
Guidance
Published
15 Jun 2026 20:40
Source
Stock Traders Daily
Bez Kabli Direct company coverage

Haleon slips as company hints at further buybacks, eyes stay on July earnings

Haleon's stock slipped 0.12% in London to 336.40p, with investors remaining cautious after a rocky start to 2026, despite hints of further share buybacks. The company canceled over 565,000 shares from its 2026 buyback program and is actively pursuing a £500 million buyback, funde

Tone
Negative 41/100
Event
Capital return
Published
15 Jun 2026 14:39
Source
Bez Kabli
Stock Titan Direct company coverage

Haleon (NYSE: HLN) repurchases and cancels 565,285 shares in buyback

Haleon plc announced it repurchased and canceled 565,285 ordinary shares on June 8, 2026, as part of its share buyback program initiated on March 12, 2026. The shares were bought on the London Stock Exchange at prices ranging from 330.5000p to 335.0000p, with a volume-weighted av

Tone
Positive 63/100
Event
Capital return
Published
15 Jun 2026 09:39
Source
Stock Titan
Bez Kabli Direct company coverage

Haleon stock moves higher as buybacks, U.S. momentum, July report watched

Haleon's stock rose 0.84% on Friday, driven by an ongoing share buyback program and strong performance in its Oral Health division, particularly in North America. Investors are anticipating the company's H1 2026 results on July 30 for further indications of growth, as risks like

Tone
Positive 60/100
Event
Capital return
Published
13 Jun 2026 20:41
Source
Bez Kabli
AD HOC NEWS Direct company coverage

Haleon plc Stock (GB00BMX86B70): Valuation and fundamentals in focus

The article provides an overview of Haleon plc (GB00BMX86B70), a global consumer health company, focusing on its market valuation, fundamental strengths, and dividend profile. It highlights Haleon's status as a large-cap defensive play within the healthcare sector, its diverse po

Tone
Neutral 50/100
Event
Capital return
Published
13 Jun 2026 17:41
Source
AD HOC NEWS
Manufacturing Today India Direct company coverage

Haleon to build new India Plant in Madhya Pradesh

Haleon plans to construct a new manufacturing plant in Pithampur, Madhya Pradesh, to produce oral health products under the Sensodyne brand. This investment highlights India's strategic importance as a growth market for Haleon, aiming to meet rising domestic and international dem

Tone
Positive 80/100
Event
Market update
Published
13 Jun 2026 11:39
Source
Manufacturing Today India
Bez Kabli Direct company coverage

Haleon Stock Moves Up After £175m India Bet

Haleon's stock moved up after the company announced plans to invest £175 million in a new oral-health plant in India, aiming to boost long-term growth and rural distribution. While the India initiative is a strategic move for the consumer health giant, its impact on earnings is e

Tone
Positive 64/100
Event
Earnings
Published
12 Jun 2026 15:09
Source
Bez Kabli
Investing.com UK Direct company coverage

Haleon completes purchase of 16.6 million shares for cancellation

Haleon plc announced it has completed the purchase and cancellation of 16,585,448 ordinary shares as part of its share buyback program. These transactions occurred between June 1 and June 4 across various exchanges, with prices ranging from 317.9 pence to 334.1 pence per share. F

Tone
Neutral 50/100
Event
Capital return
Published
09 Jun 2026 16:40
Source
Investing.com UK
AD HOC NEWS Direct company coverage

Haleon plc stock (GB00BMX86B70): Consumer health specialist updates investors after Q1 2026 trading

Haleon plc has released its Q1 2026 trading update, affirming its full-year guidance and providing insights into its growth, margins, and cash generation. The consumer health specialist, listed on both the London Stock Exchange and NYSE, reported continued strength in oral health

Tone
Positive 63/100
Event
Guidance
Published
09 Jun 2026 15:23
Source
AD HOC NEWS
Swarajyamag Direct company coverage

Sensodyne Maker Haleon To Build First India Plant In Madhya Pradesh With Rs 2,000-Crore Investment

Haleon, the maker of Sensodyne, plans to invest nearly Rs 2,000 crore (£175 million) to establish its first manufacturing unit in India, located in Pithampur, Madhya Pradesh. This greenfield facility will focus on oral care products, aiming to start operations by 2029-30 and cate

Tone
Positive 75/100
Event
Market update
Published
09 Jun 2026 06:09
Source
Swarajyamag
Stock Titan Direct company coverage

Haleon (NYSE: HLN) reports June 2026 share buyback activity

Haleon plc announced significant share buyback activity between June 1 and June 4, 2026, repurchasing 16,585,448 ordinary shares for cancellation. This action is part of a buyback program initiated on March 12, 2026, and has resulted in an updated registered share capital and rev

Tone
Positive 62/100
Event
Capital return
Published
08 Jun 2026 19:40
Source
Stock Titan
DirectorsTalk Interviews Direct company coverage

Haleon Plc (HLN) Stock Analysis: Analysts See A 28.73% Upside For This Healthcare Giant

Haleon Plc (HLN), a leading healthcare company, is attracting investor attention with a potential 28.73% upside based on analyst target prices. The company, known for brands like Sensodyne and Advil, boasts a healthy return on equity and offers a 2.12% dividend yield, complemente

Tone
Positive 72/100
Event
Analyst action
Published
08 Jun 2026 16:09
Source
DirectorsTalk Interviews
MarketWatch Direct company coverage

Haleon falls Monday, underperforms market

Haleon PLC shares dropped 1.78% to £3.31 on Monday, underperforming the FTSE 100 Index which rose slightly. The company's stock closed 20.45% below its 52-week high reached in February.

Tone
Negative 30/100
Event
Market update
Published
08 Jun 2026 12:05
Source
MarketWatch
Business Wire Direct company coverage

Haleon Invests in India to Deliver Better Everyday Health to Rural Communities

Haleon is investing approximately £175 million to expand its business in India, focusing on building a new oral health manufacturing site in Madhya Pradesh and accelerating distribution in rural areas. This strategic move aims to reach one billion more consumers globally by 2030,

Tone
Positive 71/100
Event
Market update
Published
08 Jun 2026 09:39
Source
Business Wire